M Guiguet

Summary

Country: France

Publications

  1. ncbi Hepatic steatosis in HIV-HCV coinfected patients receiving antiretroviral therapy is associated with HCV-related factors but not antiretrovirals
    Valrie Martinez
    Service de Mdecine Interne et Immunologie Clinique, Assistance publique Hpitaux de Paris, INSERM UMR_S 996, Universit Paris Sud, Hpital Antoine Bclre, 157 rue de la Porte de Trivaux, 92141 Clamart, France
    BMC Res Notes 5:180. 2012
  2. ncbi Influence of control selection in nested case-control studies: the example of exposure to antiretroviral treatment (ART) and the risk of myocardial infarction (MI) in the French Hospital Database on HIV (FHDH-ANRS CO4)
    M Guiguet
    INSERM U 720, Paris, France
    Pharmacoepidemiol Drug Saf 17:468-74. 2008
  3. ncbi HIV-associated Isospora belli infection: incidence and risk factors in the French Hospital Database on HIV
    M Guiguet
    INSERM U720, Paris, France
    HIV Med 8:124-30. 2007
  4. ncbi CD4+ T-cell percentage is an independent predictor of clinical progression in AIDS-free antiretroviral-naive patients with CD4+ T-cell counts >200 cells/mm3
    Marguerite Guiguet
    INSERM U943, Paris, France
    Antivir Ther 14:451-7. 2009
  5. ncbi Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study
    Marguerite Guiguet
    INSERM U943 and UPMC UMR S 943, Paris, France
    Lancet Oncol 10:1152-9. 2009
  6. ncbi Marked increase in the incidence of invasive anal cancer among HIV-infected patients despite treatment with combination antiretroviral therapy
    Christophe Piketty
    AP HP, Department of Clinical Immunology, Georges Pompidou European Hospital, Rene Descartes University, Paris, France
    AIDS 22:1203-11. 2008
  7. ncbi How does loss to follow-up influence cohort findings on HIV infection? A joint analysis of the French hospital database on HIV, Mortalité 2000 survey and death certificates
    E Lanoy
    INSERM, U720, Paris, France
    HIV Med 10:236-45. 2009
  8. ncbi Causes of the first AIDS-defining illness and subsequent survival before and after the advent of combined antiretroviral therapy
    S Grabar
    Department of Public Health, Cochin Hospital, Paris, France
    HIV Med 9:246-56. 2008
  9. ncbi Impact of HIV infection on severity of imported malaria is restricted to patients with CD4 cell counts < 350 cells/microl
    Christian Mouala
    INSERM U943, 56 Boulevard V Auriol, Paris Cedex 13, France
    AIDS 23:1997-2004. 2009
  10. ncbi Survival after neuroAIDS: association with antiretroviral CNS Penetration-Effectiveness score
    E Lanoy
    INSERM U943, 56 Bd V Auriol, Paris Cedex 13, France
    Neurology 76:644-51. 2011

Detail Information

Publications23

  1. ncbi Hepatic steatosis in HIV-HCV coinfected patients receiving antiretroviral therapy is associated with HCV-related factors but not antiretrovirals
    Valrie Martinez
    Service de Mdecine Interne et Immunologie Clinique, Assistance publique Hpitaux de Paris, INSERM UMR_S 996, Universit Paris Sud, Hpital Antoine Bclre, 157 rue de la Porte de Trivaux, 92141 Clamart, France
    BMC Res Notes 5:180. 2012
    ..In HIV and hepatitis C virus (HCV) coinfected patients, the role of antiretroviral therapy (ART) on hepatic steatosis (HS) remains controversial...
  2. ncbi Influence of control selection in nested case-control studies: the example of exposure to antiretroviral treatment (ART) and the risk of myocardial infarction (MI) in the French Hospital Database on HIV (FHDH-ANRS CO4)
    M Guiguet
    INSERM U 720, Paris, France
    Pharmacoepidemiol Drug Saf 17:468-74. 2008
    ..With the previous full cohort analysis as reference, we investigated the influence of control selection in nested case-control studies sampled in this cohort by testing nine sampling scenarios...
  3. ncbi HIV-associated Isospora belli infection: incidence and risk factors in the French Hospital Database on HIV
    M Guiguet
    INSERM U720, Paris, France
    HIV Med 8:124-30. 2007
    ..To determine the incidence of Isospora belli infection in HIV-infected patients in France, and to study risk factors...
  4. ncbi CD4+ T-cell percentage is an independent predictor of clinical progression in AIDS-free antiretroviral-naive patients with CD4+ T-cell counts >200 cells/mm3
    Marguerite Guiguet
    INSERM U943, Paris, France
    Antivir Ther 14:451-7. 2009
    ....
  5. ncbi Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study
    Marguerite Guiguet
    INSERM U943 and UPMC UMR S 943, Paris, France
    Lancet Oncol 10:1152-9. 2009
    ..We examined the effect of these factors on the risk of specific cancers in patients infected with HIV-1...
  6. ncbi Marked increase in the incidence of invasive anal cancer among HIV-infected patients despite treatment with combination antiretroviral therapy
    Christophe Piketty
    AP HP, Department of Clinical Immunology, Georges Pompidou European Hospital, Rene Descartes University, Paris, France
    AIDS 22:1203-11. 2008
    ..To describe the cases of anal cancer that appeared in the French Hospital Database on HIV between 1992 and 2004 and to study risk factors of anal cancer...
  7. ncbi How does loss to follow-up influence cohort findings on HIV infection? A joint analysis of the French hospital database on HIV, Mortalité 2000 survey and death certificates
    E Lanoy
    INSERM, U720, Paris, France
    HIV Med 10:236-45. 2009
    ....
  8. ncbi Causes of the first AIDS-defining illness and subsequent survival before and after the advent of combined antiretroviral therapy
    S Grabar
    Department of Public Health, Cochin Hospital, Paris, France
    HIV Med 9:246-56. 2008
    ....
  9. ncbi Impact of HIV infection on severity of imported malaria is restricted to patients with CD4 cell counts < 350 cells/microl
    Christian Mouala
    INSERM U943, 56 Boulevard V Auriol, Paris Cedex 13, France
    AIDS 23:1997-2004. 2009
    ..To study the relative impact of HIV-1 infection and associated immunodepression on the severity of Plasmodium falciparum malaria in adults returning from areas of endemic malaria...
  10. ncbi Survival after neuroAIDS: association with antiretroviral CNS Penetration-Effectiveness score
    E Lanoy
    INSERM U943, 56 Bd V Auriol, Paris Cedex 13, France
    Neurology 76:644-51. 2011
    ....
  11. ncbi Comparative effectiveness of continuing a virologically effective first-line boosted protease inhibitor combination or of switching to a three-drug regimen containing either efavirenz, nevirapine or abacavir
    T Bommenel
    INSERM U943, Paris F 75013, France
    J Antimicrob Chemother 66:1869-77. 2011
    ....
  12. ncbi Viral efficacy maintained and safety parameters improved with a reduced dose of stavudine: a pilot study
    H Ait-Mohand
    Service de Maladies Infectieuses et Tropicales, Assistance Publique Hopitaux de Paris AP HP, Groupe Hospitalier Pitie Salpetriere, Paris, France
    HIV Med 9:738-46. 2008
    ..Stavudine (d4T) is a potent but potentially toxic nucleoside reverse transcriptase inhibitor that is still widely used in developing countries. This study's aim was to determine the efficacy and safety profile of lower-dose d4T...
  13. ncbi Impact of highly active antiretroviral therapy on the occurrence of bacteraemia in HIV-infected patients and their epidemiologic characteristics
    J L Meynard
    Service des Maladies Infectieuses et Tropicales, Hopital Saint Antoine, INSERM U 444, Faculte de Medecine Saint Antoine, and Laboratoire de Bacteriologie, Hopital Saint Antoine, Paris, France
    HIV Med 4:127-32. 2003
    ..2. to identify risk factors for bacteraemia in this setting...
  14. ncbi HIV-associated tuberculosis and immigration in a high-income country: incidence trends and risk factors in recent years
    Sophie Abgrall
    INSERM U 943, Hopital Avicenne, Service de maladies infectieuses ettropicales, Bobigny, France
    AIDS 24:763-71. 2010
    ..To examine trends in tuberculosis incidence rates in France during the combination antiretroviral therapy (cART) period...
  15. ncbi [Comparison of infectious complications of long-term and short-term central venous catheterization]
    M Guiguet
    CLIN, Hopital St Antoine, Paris
    Presse Med 28:1347-51. 1999
    ..Risk factors for infectious complications of central venous catheters (CVC) were compared between CVC used for short and long periods to identify patients at risk...
  16. ncbi Reliability of report coding of hospital referrals in primary care versus practice-based coding
    L Letrilliart
    INSERM Unit 444, WHO Collaborating Centre for Electronic Disease Surveillance, Paris, France
    Eur J Epidemiol 16:653-9. 2000
    ..We conclude that centralized coding is a reliable alternative to practice-based coding in primary care, provided that physicians give sufficiently specific information...
  17. ncbi Serum adiponectin and metabolic parameters in HIV-1-infected patients after substitution of nevirapine for protease inhibitors
    J M Petit
    Hopital Universitaire du Bocage, Dijon, France
    Eur J Clin Invest 34:569-75. 2004
    ..The aim of the present study was to examine whether adiponectin concentration or insulin sensitivity level correlate with the modifications of lipid parameters after the switch of PI by nevirapine...
  18. ncbi Major hypertriglyceridemia in HIV-infected patients on antiretroviral therapy: a role of the personal and family history
    D Bollens
    Infectious Diseases Unit, Saint Antoine Hospital, 184 rue du Faubourg, Saint-Antoine, 75571, Paris Cedex 12, France
    Infection 32:217-21. 2004
    ..6, CI: 1.3-9.9). CONCLUSION: By identifying subgroups of highly predisposed patients, appropriate lifestyle and dietary measures could be recommended on ART initiation...
  19. ncbi [Predictive factors of virologic response to antiretroviral treatment with a protease inhibitor in HIV infection]
    J L Meynard
    Service des Maladies Infectieuses et Tropicales, Centre Hospitalo-Universitaire Saint-Antoine-AP-HP-Paris VI
    Presse Med 30:5-10. 2001
    ....
  20. ncbi [Complications due to peripheral venous catheterization. Prospective study]
    F Barbut
    Unité d hygiène et de lutte contre les infections nosocomiales UHLIN Hôpital Saint Antoine 184, rue du Faubourg Saint Antoine 75012 Paris
    Presse Med 32:450-6. 2003
    ..Peripheral venous catheter (PVC)-associated complications were prospectively evaluated in a 2 month-study performed in 3 different wards...
  21. ncbi Postdischarge nosocomial infections in primary care
    L Letrilliart
    Unit 444, WHO Collaborating Center for Electronic Disease Surveillance, National Institute for Health and Medical Research, Paris 6 University, France
    Infect Control Hosp Epidemiol 22:493-8. 2001
    ..8% following nonsurgical admissions. The percentage of postdischarge visits that were for an NI in nonsurgical patients warrants a major effort with feedback to the hospital physician to reduce infection rates...
  22. ncbi Postdischarge adverse drug reactions in primary care originating from hospital care in France: a nationwide prospective study
    L Letrilliart
    WHO Collaborating Centre for Electronic Disease Surveillance, National Institute for Health and Medical Research (INSERM, , France
    Drug Saf 24:781-92. 2001
    ..Patient information in hospital, close postdischarge follow-up of patients at risk, and appropriate transmission of information between hospital physicians and GPs can help to prevent them...
  23. ncbi [Evaluation of compliance with antiretroviral treatment in a cohort of 200 patients in Djibouti, 2005]
    A A Ahmed
    Ministere de la Sante, Djibouti
    East Mediterr Health J 13:1286-97. 2007
    ..In multivariate analysis, community support and level of education protected against non-compliance. Patients having already missed a dose and those dissatisfied with confidentiality had a 4 times greater risk of non-compliance...